Herd immunity with new COVID variants?

  • Thread starter Thread starter ElliotSmith
  • Start date Start date
  • Tags Tags
    Covid
Click For Summary

Discussion Overview

The discussion revolves around the topic of immunity to new COVID-19 variants, particularly in relation to antibodies generated from natural infection versus those produced by vaccinations. Participants explore the implications of these immune responses on protection against emerging variants and the role of T cells in immunity.

Discussion Character

  • Exploratory
  • Technical explanation
  • Debate/contested

Main Points Raised

  • Some participants question whether individuals who survived the original COVID-19 strain have any immunity to new variants, suggesting uncertainty about the effectiveness of antibodies against these variants.
  • Others explain that antibodies from natural infection target multiple parts of the virus, while vaccines may produce antibodies that focus on a specific part of the virus, potentially affecting their effectiveness against variants.
  • It is noted that while antibodies from natural infection may vary in effectiveness against new challenges, T cell responses remain largely unaffected by variants, which may contribute to continued protection against severe disease.
  • One participant shares personal experiences with COVID-19 and seeks to provide resources for others affected by the virus, indicating a shift in focus from the scientific discussion to personal narratives.
  • A later post discusses specific antibodies that show promise in resisting viral escape and maintaining effectiveness across different variants, highlighting ongoing research in the field.

Areas of Agreement / Disagreement

Participants express differing views on the effectiveness of antibodies from natural infection compared to those from vaccines, and whether T cell responses provide sufficient protection against new variants. The discussion remains unresolved with multiple competing perspectives presented.

Contextual Notes

Limitations include the complexity of immune responses, the evolving nature of variants, and the ongoing research into antibody effectiveness, which may not be fully addressed in the discussion.

ElliotSmith
Messages
167
Reaction score
104
TL;DR
Do natural COVID antibodies protect against the new variants?
If someone has had the original COVID-19 strain and survived, does this mean that they have any immunity to the new variants? Or do the new variants completely ignore any antibodies that someone who survived the original virus has?
 
Biology news on Phys.org
The difference between the antibodies you get from an invection vs. antibodies you might get from the new immunizations they are now producing, is that the immunizations produce antibodies to only a single part of the virus, a part deeply involed involved in infecting cells. If the antibody binding this site (epitope) doesn't directly lead to the virus's destruction, it will physically block the virus's ability to a gain entry to a cells to infect.
Antibodies acquired by being infected can be from any exposed molecular surface of the viruses (several proteins, with many different places an antibody could bind).
Antibodies, to parts of the virus's surface not targeted in the immunizations, can act as signals to immune cells to remove the virus, but until that happens, the virus is still infective.

Summary:
The antibodies from a natural infection, will raise a lot of different antibodies.
The antibodies raised by the immunization will be a sub-set of those raised by an infection, but they will be very effective.
Not all of the antibodies from a natural infection will be equally effective in fighting new challenges.
 
Last edited:
  • Like
Likes   Reactions: atyy and ElliotSmith
An important thing to keep in mind is that even if antibodies protect less against new variants, the T cells protection developed by natural infection or by Pfizer vaccines has been negligibly affected by variants. The T cell responses may help explain why the vaccines continue to provide good protection against severe disease, even though their ability to protect from infection has decreased.
https://doi.org/10.1016/j.xcrm.2021.100355
https://immunology.sciencemag.org/content/6/59/eabj1750
https://www.nature.com/articles/s41586-021-03681-2
 
  • Informative
  • Like
Likes   Reactions: bhobba and BillTre
Hi Friends,

I was affected by COVID wave 2, It drained my energy level as well myself confidence. I got headache pain, and cold, and sneezing heavily... And also I faced hair fall issues... And then I have started browsing the information related to COVID and how to overcome this... I was read the many websites and I have shared the websites here. If anyone seeking or getting benefits from this one reply me here...

https://reliefseeker.com/news/hair-loss-treatment-guide
 

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape​

Here we comprehensively characterize escape, breadth and potency across a panel of SARS-CoV-2 antibodies targeting the receptor-binding domain (RBD). Despite a trade-off between in vitro neutralization potency and breadth of sarbecovirus binding, we identify neutralizing antibodies with exceptional sarbecovirus breadth and a corresponding resistance to SARS-CoV-2 escape. One of these antibodies, S2H97, binds with high affinity across all sarbecovirus clades to a cryptic epitope and prophylactically protects hamsters from viral challenge. Antibodies that target the angiotensin-converting enzyme 2 (ACE2) receptor-binding motif (RBM) typically have poor breadth and are readily escaped by mutations despite high neutralization potency. Nevertheless, we also characterize a potent RBM antibody (S2E128) with breadth across sarbecoviruses related to SARS-CoV-2 and a high barrier to viral escape. These data highlight principles underlying variation in escape, breadth and potency among antibodies that target the RBD, and identify epitopes and features to prioritize for therapeutic development against the current and potential future pandemics.
https://www.nature.com/articles/s41586-021-03807-6
 

Similar threads

  • · Replies 562 ·
19
Replies
562
Views
36K
  • · Replies 22 ·
Replies
22
Views
4K
  • · Replies 516 ·
18
Replies
516
Views
38K
  • · Replies 4 ·
Replies
4
Views
1K
Replies
1
Views
2K
  • · Replies 1 ·
Replies
1
Views
4K
Replies
11
Views
2K
  • · Replies 1 ·
Replies
1
Views
2K
Replies
26
Views
3K
Replies
4
Views
2K